Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2003-7-9
pubmed:abstractText
Hepatitis B virus (HBV) genotype may influence disease progression and antiviral response. We therefore analyzed the frequency and distribution of genotypes in patients from 2 multinational phase III studies of adefovir dipivoxil. Antiviral efficacy of adefovir dipivoxil 10-mg therapy was examined with respect to HBV genotype, hepatitis B e antigen (HBeAg) serostatus, and race.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
0016-5085
pubmed:author
pubmed:issnType
Print
pubmed:volume
125
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
107-16
pubmed:dateRevised
2004-11-17
pubmed:meshHeading
pubmed-meshheading:12851876-Adenine, pubmed-meshheading:12851876-Adult, pubmed-meshheading:12851876-Antiviral Agents, pubmed-meshheading:12851876-Asia, pubmed-meshheading:12851876-Continental Population Groups, pubmed-meshheading:12851876-DNA, Viral, pubmed-meshheading:12851876-Europe, pubmed-meshheading:12851876-Female, pubmed-meshheading:12851876-Genotype, pubmed-meshheading:12851876-Hepatitis B, Chronic, pubmed-meshheading:12851876-Hepatitis B e Antigens, pubmed-meshheading:12851876-Hepatitis B virus, pubmed-meshheading:12851876-Humans, pubmed-meshheading:12851876-Male, pubmed-meshheading:12851876-Middle Aged, pubmed-meshheading:12851876-North America, pubmed-meshheading:12851876-Pacific Islands, pubmed-meshheading:12851876-Phosphonic Acids, pubmed-meshheading:12851876-Phylogeny, pubmed-meshheading:12851876-Prevalence, pubmed-meshheading:12851876-Retrospective Studies
pubmed:year
2003
pubmed:articleTitle
Hepatitis B virus genotypes and virologic response in 694 patients in phase III studies of adefovir dipivoxil1.
pubmed:affiliation
Gilead Sciences, Foster City, California 94404, USA.
pubmed:publicationType
Journal Article, Clinical Trial, Randomized Controlled Trial, Multicenter Study, Clinical Trial, Phase III